In this session, we will delve into the complex landscape of policy changes affecting patient access to healthcare. We will explore two key areas: Inflation Reduction Act (IRA) in the United States and Health Technology Assessment (HTA) in Europe.

Our expert speakers will provide a comprehensive understanding of these policy changes, their objectives, implementation timelines, and associated challenges.

Key learnings:

• Understanding policy changes and timelines: Overview of IRA in the US and EU HTA in Europe, key objectives and implementation timelines, key challenges
• Considerations for stakeholders, including biopharma companies, healthcare providers, payers, and patients: Ensuring alignment and collaboration, leveraging data-driven insights for informed decision-making, strategies at national level, tools and resources to accelerate patient access
• Q&A with the audience

Join us for an engaging session where you will gain valuable insights into navigating policy changes and discover strategies to ensure patient access amidst the evolving landscape of IRA and EU HTA.